Development of a FibroScan Liver Examination Using a Single Probe
Recruiting
N/A
Interventional Study
Liver Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 389 (estimated)
- Sponsor
- Echosens · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (≥ 18 years of age).
* Patient followed with a chronic liver disease.
* Adult patient able to give his written consent.
* For European sites: patient affiliated to the healthcare system.
Exclusion Criteria:
* Vulnerable patients.
* Patients with ascites.
* Pat…
Contacts